Thousands of Stock Trades Tied to Trump Under BBC Spotlight USIran Deal Progress Revives Strait of Hormuz Concerns as Trump Ally Warns of Security Risks Trump Administration Policy Would Require Foreigners to Leave US for Green Card Applications Raising Business Concerns SpaceX Scrubs Starship V3 Test Flight Rescheduled for Friday Launch Bank Closures on Memorial Day Key Federal Holidays for Financial Planning China Emerges as Leading Competitor in Humanoid Robot Race Elon Musk Warns SOHOO Q2 2025 Earnings Preferred Dividend Coverage Maintained Amid Stable Operations DBX Q1 2026 Earnings EPS Beats Estimates by 8 Amid Modest Stock Uptick ICFI Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises on Positive Market Sentiment CLB Q1 2026 Earnings EPS Miss Weighs on Results Stock Gains Despite Disappointing Profitability KGC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage Rumble Inc RUM Edges Higher as Support Holds Near 779 Gen Digital CVRs Surge 2063 to 152 Approaching Key Resistance Piper Sandler PIPR Edges Lower Amid Consolidation Near Key Support INDO Stock Drops Over 11 Testing Key Support Levels Riley Exploration Permian REPX Holds Near Key Support After Marginal Decline Carney Says Alberta Essential to Canada as Province Moves Toward Separation Referendum iQSTEL Inc Q4 2025 Earnings EPS Misses Estimates Significantly CDTTW Warrants Remain Static at 001 Analysis of Current Stalemate KKR Income Opportunities Fund KIO Edges Higher as YieldSeekers Eye Key Support Levels GigaCloud Technology GCT Holds Steady Near Support Sideways Trading Signals Caution Hercules Capital 625 Notes HCXY Edge Higher Amid Stable Credit Conditions Leapfrog Acquisition Warrants LFACW Trade Tight Range as Price Holds at 028 Jazz Pharmaceuticals JAZZ Experiences Modest Decline Following Recent RunUp Eaton Vance Diversified Equity Income Fund ETY Edges Higher Amid Cautious Trading UroGen Pharma URGN Advances 197 Approaching Key Resistance at 3093